CAS 2023788-19-2

Tirzepatida

Descripción:

Tirzepatida es un péptido sintético novel que funciona como un agonista dual para los receptores del péptido similar al glucagón-1 (GLP-1) y el polipéptido insulinotrópico dependiente de glucosa (GIP). Se desarrolla principalmente para el tratamiento de la diabetes tipo 2 y la obesidad. La sustancia se caracteriza por su estructura única, que le permite aumentar la secreción de insulina en respuesta a las comidas, reducir los niveles de glucagón y promover la saciedad, ayudando así en el control glucémico y la gestión del peso. Tirzepatida tiene una larga vida media, lo que permite una administración una vez a la semana, mejorando la adherencia del paciente en comparación con los medicamentos diarios. Su mecanismo de acción implica imitar los efectos de las hormonas incretinas, lo que lleva a una mejora en el metabolismo de la glucosa. Los estudios clínicos han mostrado una eficacia significativa en la reducción de los niveles de azúcar en sangre y en la promoción de la pérdida de peso en individuos con diabetes tipo 2. Como con cualquier medicamento, los efectos secundarios potenciales pueden incluir problemas gastrointestinales, y es esencial que los pacientes consulten a profesionales de la salud para obtener asesoramiento personalizado y monitoreo durante el tratamiento.

Sinónimos:

• Tianeptine  Sodium

Tirzepatide

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: 99%

Forma y color: Solid

Peso molecular: 4813.4514

Ref: IN-DA01MVDA

Tirzepatide

CAS: 2023788-19-2

Tirzepatide (LY-3298176) is a dual glucose-dependent polypeptide (GIP) (EC50=0.042 nM) and glucagon-like peptide-1 (GLP-1) (EC50=0.086 nM) receptor agonist.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: 99.52% - 99.99%

Forma y color: Solid

Peso molecular: 4813.45

Ref: TM-TP1111

Tirzepatide sodium salt

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈·Nax

Pureza: ≥ 95.0%

Forma y color: White to off-white powder or solid

Peso molecular: 4813.45 (ex. Na)

Ref: 7W-GP2780

Tirzepatide

CAS: 2023788-19-2

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Peso molecular: 4813.53

Ref: 4Z-PT-453001

Tirzepatide sodium

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈•xNa

Pureza: Min. 95 Area-%

Forma y color: Powder

Ref: 3D-BT183282

Tirzepatide

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Fórmula: C₂₂₅H₃₄₈N₄₈O₆₈

Pureza: Min. 95%

Forma y color: Powder

Peso molecular: 4,813 g/mol

Ref: 3D-FT181880

Tirzepatide acetate

CAS: 2023788-19-2

Cymit Quimica provides this product solely for uses within the scope of any statute or law providing for an immunity, exemption, or exception to patent infringement (“Exempted Uses”), including but not limited to 35 U.S.C. § 271(e)(1) in the United States, the Bolar type exemption in Europe, and any corresponding exception to patent infringement in any other country. It is the sole responsibility of the purchaser or user of this product, and the purchaser or user of this product agrees to engage only in such Exempted Uses, and to comply with all applicable intellectual property laws and/or regulations. The purchaser of this product agrees to indemnify Cymit Quimica against all claims in connection with the performance of the respective commercial agreement (e.g. supply agreement) and possible infringements of intellectual property rights.

Pureza: Min. 95%

Ref: 3D-FT182420

Heavy Tirzepatide (+52Da)

CAS: 2023788-19-2

Heavy Tirzepatide (+52Da)

Pureza: Min. 95%

Peso molecular: 4,862.7 g/mol

Ref: 3D-CRB1301725